In ovarian cancer, the SPP1-CD44 axis facilitated cancer cell chemoresistance via PI3K/AKT signaling and ATP-binding cassette (ABC) drug efflux transporter activity [33]. This evidence concerns the gene AKT1 and ovarian cancer.